FindTrial
Sign In

A Study To Compare Sedative Drugs For Awake fiberoptic Nasal Intubation For Difficult Airway

A Prospective Randomised Comparative Study Between Intravenous Dexmedetomidine Versus Intravenous Fentanyl For Awake Fiberoptic Nasal Intubation In Patient With Simulated Difficult Airway - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107373
Enrollment
60
Registered
2026-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z00-Z99- Factors influencing health status and contact with health services

Interventions

Intervention1: group A- Dexmedetomidine: Intravenous dexmedetomidine 1 g/kg diluted in 100 ml normal saline administered over 10 minutes as infusion before awake fiberoptic nasal intubation. Addition

Sponsors

LLRM Medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients undergoing elective surgeries under GA

Exclusion criteria

Exclusion criteria: pregnancy cardiac disease, HTN Liver and kidney disease chronic alcoholic and addict known allergy to drug

Design outcomes

Primary

MeasureTime frame
patient tolerance score sedation score vocal cord movement cough scoreTimepoint: 1.during intubation procedure 2.immediately after successful intubation 3.sedation time points baseline after study drug infusion during intubation—

Secondary

MeasureTime frame
hemodynamic changes ( HR, MAP, SBP, CBP )Timepoint: 1. baseline 2. every 2 minutes during drug infusion 3. at key intubation steps passage through nostril nasopharynx glottis 4. after intubation;incidence of desaturationTimepoint: during drug infusion during intubation immediately after intubation;time taken for intubationTimepoint: insertion of fiberoptic scope into nostril to appearance of capnography waveform;recall & adverse effectsTimepoint: 24hrs post procedure—

Countries

India

Contacts

Public ContactSimran

LLRM medical college

Drsubhashllrm@gmail.com9837056949

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026